GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Proteome Sciences PLC (LSE:PRM) » Definitions » Operating Margin %

Proteome Sciences (LSE:PRM) Operating Margin % : -80.20% (As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Proteome Sciences Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Proteome Sciences's Operating Income for the six months ended in Dec. 2023 was £-1.46 Mil. Proteome Sciences's Revenue for the six months ended in Dec. 2023 was £1.82 Mil. Therefore, Proteome Sciences's Operating Margin % for the quarter that ended in Dec. 2023 was -80.20%.

The historical rank and industry rank for Proteome Sciences's Operating Margin % or its related term are showing as below:

LSE:PRM' s Operating Margin % Range Over the Past 10 Years
Min: -255.8   Med: -38.59   Max: 22.21
Current: -32.24


LSE:PRM's Operating Margin % is ranked worse than
61.19% of 219 companies
in the Medical Diagnostics & Research industry
Industry Median: -8.83 vs LSE:PRM: -32.24

Proteome Sciences's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Proteome Sciences's Operating Income for the six months ended in Dec. 2023 was £-1.46 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2023 was £-1.62 Mil.


Proteome Sciences Operating Margin % Historical Data

The historical data trend for Proteome Sciences's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Proteome Sciences Operating Margin % Chart

Proteome Sciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.42 11.55 8.03 22.21 -32.24

Proteome Sciences Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.39 8.23 32.20 -5.08 -80.20

Competitive Comparison of Proteome Sciences's Operating Margin %

For the Diagnostics & Research subindustry, Proteome Sciences's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Proteome Sciences's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Proteome Sciences's Operating Margin % falls into.



Proteome Sciences Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Proteome Sciences's Operating Margin % for the fiscal year that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-1.621 / 5.028
=-32.24 %

Proteome Sciences's Operating Margin % for the quarter that ended in Dec. 2023 is calculated as

Operating Margin %=Operating Income (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=-1.458 / 1.818
=-80.20 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Proteome Sciences  (LSE:PRM) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Proteome Sciences Operating Margin % Related Terms

Thank you for viewing the detailed overview of Proteome Sciences's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Proteome Sciences (LSE:PRM) Business Description

Traded in Other Exchanges
Address
Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for diagnostic, prognostic and therapeutic applications. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product. Geographically, it has a presence in the United States, the United Kingdom, and the European Union.

Proteome Sciences (LSE:PRM) Headlines

From GuruFocus

EQUITABLE TRUST CO Buys 2, Sells 3 in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-21-2023

Perimeter Announces Date for Third Quarter 2021 Earnings Call

By PRNewswire PRNewswire 12-02-2021

Perimeter Solutions Sa (PRM) COO Ernest C. Kremling Ii Bought $1.5 million of Shares

By GuruFocus Research GuruFocus Editor 11-11-2021

Perimeter Announces Date for Third Quarter 2022 Earnings Call

By PRNewswire PRNewswire 10-24-2022

Weitz Analyst Corner: Perimeter Solutions

By Sydnee Gatewood 11-29-2022

Top 5 2nd Quarter Trades of Stanley Capital Management, LLC

By GuruFocus Research GuruFocus Editor 08-16-2022

Perimeter Solutions Reports Third Quarter 2021 Results

By PRNewswire PRNewswire 12-14-2021